| MBXIX | QGMNX | MBXIX / QGMNX | |
| Total Expense Ratio | 2.00 | 1.77 | 113% |
| Annual Report Gross Expense Ratio | 2.00 | 1.77 | 113% |
| Fund Existence | 10 years | 12 years | - |
| Gain YTD | 14.910 | 0.622 | 2,398% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.4B | 1.03B | 1,010% |
| Annual Yield % from dividends | 0.00 | 1.20 | 0% |
| Returns for 1 year | 19.67 | 0.29 | 6,869% |
| Returns for 3 years | 34.55 | 2.80 | 1,233% |
| Returns for 5 years | 39.56 | 14.69 | 269% |
| Returns for 10 years | 110.01 | 22.99 | 479% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVII | 25.36 | 0.53 | +2.13% |
| REX NVDA Growth & Income ETF | |||
| KBWY | 17.97 | 0.19 | +1.08% |
| Invesco KBW Premium Yield Eq REIT ETF | |||
| XRMI | 17.33 | 0.02 | +0.12% |
| Global X S&P 500® Risk Managed Inc ETF | |||
| THNR | 24.26 | N/A | N/A |
| Amplify Weight Loss Drug & Treatment ETF | |||
| RPV | 112.87 | -0.49 | -0.43% |
| Invesco S&P 500® Pure Value ETF | |||